Our findings demonstrate that neuroendocrine marker genes and associated gene regulatory networks in SCNECO differ from those observed in pulmonary neuroendocrine carcinomas available in the GEO database, supporting a tissue specific origin for these malignancies. Collectively, this work addresses a critical gap in the understanding of SCNECO and provides valuable insights to guide chemotherapy, targeted therapy, and immunotherapy approaches.
No takes yet. Share an insight, caveat, or question.
谢广婷(Guangting Xie) (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: